Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002002483 | SCV002231242 | pathogenic | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with EYS-related conditions. This sequence change creates a premature translational stop signal (p.Trp1587*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (ExAC no frequency). |
Ce |
RCV002002483 | SCV002563905 | pathogenic | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | EYS: PVS1, PM2 |
Institute of Human Genetics, |
RCV004816822 | SCV005068398 | pathogenic | Retinal dystrophy | 2020-01-01 | no assertion criteria provided | clinical testing |